Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico

Journal of Clinical Rheumatology

Volumn 13, Issue 4, 2007, Pages 202-204

  Molina, María J ^a   Mayor, Angel M ^a   Franco, Alejandro E ^b   Morell, Carlos A ^b   López, Miguel A ^b   Vilá, Luis M ^a,c  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b Triple S Inc (Independent License of BC/BSA)   (Puerto Rico)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Comorbidities; Prevalence; Puerto Rico; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CHI SQUARE TEST; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; FISHER EXACT TEST; HEALTH INSURANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PUERTO RICO; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; BONE DISEASES, METABOLIC; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; DATABASES; DIABETES MELLITUS; FEMALE; FORMS AND RECORDS CONTROL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PUERTO RICO;

EID: 34548436094     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318124a8af     Document Type: Article

References (15)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481- 490.
2. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus. 1997;6:399-403.
3. López P, Mozo L, Gutiérrez C, et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus. 2003;12:860-865.
4. Wang F, Wang CL, Tan CT, et al. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus. 1997;6:248-253.
5. Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health. 2004;13:713-718.
6. Stahl-Hallengren C, Jonsen A, Nived O, et al. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685-691.
7. Benucci M, Li Gobbi F, Del Rosso A, et al. Systemic lupus erythematosus: the first Italian prevalence study. Reumatismo. 2005;57:103-108.
8. Naleway AL, Davis ME, Greenlee RT, et al. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus. 2005;14:862-866.
9. Hochberg MC, Perlmutter DL, Medsger TA, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus. 1995;4:454-456.
10. Vilá LM, Alarcón GS, McGwin G Jr, et al. for the LUMINA Study Group. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford). 2004;43:358 -363.
11. Vilá LM, Mayor AM, Valentín AH, et al. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus. 1999;8:279-286.
12. Alamanos Y, Voulgari PV, Siozos C, et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol. 2003;30:731-735.
13. Alarcón GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three groups. VII. Predictors of early mortality in the LUMINA cohort. LUMINA study group. Arthritis Rheum. 2001;45:191-202.
14. Bae SC, Hashimoto H, Karlson EW, et al. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol. 2001;28:1245-1251.
15. Karlson EW, Daltroy LH, Lew RA, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 1995;38:267-273.